1/24/2023 6:29:07 AM
Johnson & Johnson Q4 EPS $1.33; Adj EPS $2.35
11/30/2022 6:48:21 PM
Johnson & Johnson Names CEO Joaquin Duato As Chairman Of The Board
11/1/2022 6:34:38 AM
Johnson & Johnson To Acquire Abiomed For An Upfront Payment Of
$380/Shr Cash
10/18/2022 6:33:23 AM
Johnson & Johnson Q3 EPS $1.68; Adjusted EPS $2.55
10/18/2022 6:30:31 AM
Johnson & Johnson Q3 EPS $1.68 Vs $1.37 Last Year